Published in J Virol on September 01, 2001
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol (2011) 2.87
Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol (2005) 2.65
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood (2009) 2.55
Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther (2007) 1.94
Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J Biol Chem (2011) 1.73
Adenovirus receptors. J Virol (2005) 1.55
Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev (2013) 1.49
CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. J Virol (2005) 1.37
Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther (2006) 1.34
Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J Virol (2002) 1.33
Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol (2012) 1.28
Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS Pathog (2007) 1.28
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res (2009) 1.20
Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses (2010) 1.17
Innate immunity to adenovirus. Hum Gene Ther (2014) 1.15
Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein. J Virol (2003) 1.11
Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol (2006) 1.09
Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J Virol (2003) 1.06
Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity. J Virol (2006) 1.03
Homotrimeric, beta-stranded viral adhesins and tail proteins. J Bacteriol (2003) 1.02
Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. J Virol (2005) 1.00
Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J Virol (2006) 1.00
Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med (2006) 0.99
Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo. J Virol (2007) 0.98
Adenovirus receptors and their implications in gene delivery. Virus Res (2009) 0.98
Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. J Virol (2004) 0.97
Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells. J Virol (2009) 0.95
Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin. J Virol (2002) 0.94
Adenoviral vectors for improved gene delivery to the inner ear. Hear Res (2008) 0.92
Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers. J Virol (2006) 0.89
Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1. J Virol (2009) 0.88
DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice. J Clin Invest (2009) 0.88
p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker. Mol Cancer (2010) 0.87
A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer. Gene Ther (2006) 0.87
Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin. J Virol (2003) 0.87
Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction. PLoS One (2011) 0.87
A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans. J Virol (2014) 0.85
α2-3- and α2-6- N-linked sialic acids allow efficient interaction of Newcastle Disease Virus with target cells. Glycoconj J (2012) 0.84
Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells. Virol J (2010) 0.84
Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus. J Virol (2009) 0.83
Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob Agents Chemother (2003) 0.82
Function of membrane rafts in viral lifecycles and host cellular response. Biochem Res Int (2011) 0.82
Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs. J Virol (2007) 0.82
Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate. Viruses (2015) 0.81
The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus. Biomaterials (2011) 0.81
Retargeting adenoviral vectors to improve gene transfer into tumors. Cancer Gene Ther (2010) 0.81
Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment. Hum Gene Ther (2009) 0.81
Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody. J Mol Biol (2009) 0.80
Interaction between mouse adenovirus type 1 and cell surface heparan sulfate proteoglycans. PLoS One (2012) 0.80
Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regen (2006) 0.80
Optimizing atoh1-induced vestibular hair cell regeneration. Laryngoscope (2014) 0.80
The Mucus Barrier to Inhaled Gene Therapy. Mol Ther (2016) 0.79
Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J Virol (2009) 0.78
Peptide targeting of adenoviral vectors to augment tumor gene transfer. Cancer Gene Ther (2012) 0.78
Adenoviral transduction of enterocytes and M-cells using in vitro models based on Caco-2 cells: the coxsackievirus and adenovirus receptor (CAR) mediates both apical and basolateral transduction. Mol Pharm (2010) 0.78
Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice. Hum Gene Ther (2008) 0.77
Emerging roles for ubiquitin in adenovirus cell entry. Biol Cell (2012) 0.77
Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors. Clin Cancer Res (2008) 0.76
Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes. J Virol (2003) 0.76
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism. PLoS One (2013) 0.75
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (1997) 14.41
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell (1993) 13.21
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol (1998) 8.45
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol (1989) 7.11
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A (1997) 6.92
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med (1997) 6.57
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med (1999) 5.50
AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med (1999) 5.26
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol (1996) 4.97
Three classes of cell surface receptors for alphaherpesvirus entry. Virology (2000) 4.41
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol (1998) 4.26
Regulated diversity of heparan sulfate. J Biol Chem (1998) 3.93
Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science (1999) 3.24
Microbial adherence to and invasion through proteoglycans. Infect Immun (1997) 3.22
Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem (1999) 3.04
Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol (1994) 2.92
Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61
Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science (1999) 2.56
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol (1998) 2.45
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J (1997) 2.43
Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol (2000) 2.38
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol (1996) 2.38
Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J Clin Invest (1997) 2.33
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther (1998) 2.27
Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol (1998) 2.20
Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol (2000) 2.08
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1993) 2.07
Update on adenovirus and its vectors. J Gen Virol (2000) 1.93
Adenovirus internalization and infection require dynamin. J Virol (1998) 1.78
Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology (2000) 1.77
Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J Virol (1999) 1.62
Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem (2000) 1.43
The interaction of heparin sulfate and adeno-associated virus 2. Virology (2000) 1.28
Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J Gen Virol (2000) 1.28
Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J Biol Chem (1998) 1.21
Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. J Biol Chem (1999) 1.13
Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter. J Virol (2001) 1.05
Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate. J Biol Chem (1999) 0.97
Proteoglycans in cell regulation. Crit Rev Clin Lab Sci (1992) 0.91
Improvements in adenoviral vector technology: overcoming barriers for gene therapy. Clin Genet (2000) 0.91
Differential expression of transmembrane proteoglycans in vascular smooth muscle cells. J Biol Chem (1993) 0.88
Diffuse panbronchiolitis. Eur Respir J (2006) 2.91
Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J (2003) 2.15
CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J (2012) 2.11
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
Mite-antigen avoidance can reduce bronchial epithelial shedding in allergic asthmatic children. Clin Exp Allergy (1998) 2.00
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood (2001) 1.79
Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology (2000) 1.77
CD30 and type 2 T helper (Th2) responses. J Leukoc Biol (1995) 1.72
Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56
Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation. Leukemia (1994) 1.54
The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: pro. Rev Port Pneumol (2011) 1.54
Phenotypic intrafamilial heterogeneity in cystic fibrosis. Clin Genet (1993) 1.53
Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood (1991) 1.52
The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences. Genomics (1991) 1.51
Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. Am J Clin Pathol (1989) 1.47
Analysis of 14 cystic fibrosis mutations in five south European populations. Hum Genet (1991) 1.40
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung. Pathologica (2010) 1.34
Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. J Biol Chem (1994) 1.33
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest (1985) 1.30
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann N Y Acad Sci (1986) 1.30
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med (1982) 1.28
Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc Natl Acad Sci U S A (1995) 1.26
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood (2000) 1.25
Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity. Mol Cell Biol (1995) 1.24
Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. Am J Pathol (1999) 1.21
Combined immunological and histochemical analysis of skin and lymph node lesions in histiocytosis X. J Clin Pathol (1982) 1.18
Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis (1985) 1.18
Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: the use of cryostat sections. Br J Cancer (1983) 1.15
Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol (2001) 1.15
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol (2009) 1.15
Peripheral giant cell granuloma: evidence for osteoclastic differentiation. Oral Surg Oral Med Oral Pathol (1990) 1.14
Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene (1999) 1.14
Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease. J Med Genet (1992) 1.13
Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: their incidence and clinical features of defined genotypes. Hum Mutat (1993) 1.12
Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am J Pathol (1985) 1.12
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (1988) 1.10
Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. Biochem J (1984) 1.10
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders. Br J Haematol (1982) 1.10
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer (1987) 1.09
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol (2006) 1.08
Epidemiology and a novel procedure for large scale analysis of CFTR rearrangements in classic and atypical CF patients: a multicentric Italian study. J Cyst Fibros (2008) 1.05
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer (2007) 1.04
Pulmonary features of Birt-Hogg-Dubé syndrome: cystic lesions and pulmonary histiocytoma. Respir Med (2011) 1.04
Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol (1984) 1.03
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun (2010) 1.01
Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer (1984) 1.00
Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations. Hum Genet (1995) 1.00
Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn Mol Pathol (1995) 1.00
Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells. Blood (1998) 1.00
Small-cell neuroendocrine carcinoma of the ampullary region. A clinicopathologic, immunohistochemical, and ultrastructural study of three cases. Am J Surg Pathol (1990) 0.99
The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease. Monaldi Arch Chest Dis (2008) 0.98
Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections. Virchows Arch A Pathol Anat Histopathol (1988) 0.97
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood (1987) 0.97
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions. Clin Exp Immunol (1984) 0.97
Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown. J Neuroimmunol (1986) 0.97
Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia. Blood (1983) 0.96
Immunohistological study in sarcoidosis: evaluation at different sites of disease activity. Clin Immunol Immunopathol (1984) 0.96
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. Cancer (1985) 0.96
Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood (1985) 0.96
Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas. Hematol Pathol (1991) 0.96
The soluble interleukin-2 receptor in haematological disorders. Br J Haematol (1987) 0.96
Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases. Am J Pathol (1987) 0.95
Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res (1996) 0.95
Double knockout of the ALL-1 gene blocks hematopoietic differentiation in vitro. Cancer Res (1996) 0.95
Enzyme histochemistry on normal and pathologic paraffin-embedded lymphoid tissues. Am J Clin Pathol (1981) 0.95
Acute interstitial pneumonia: report of a series. Eur Respir J (2003) 0.95
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur Respir J (2011) 0.94
Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis. Hum Mutat (2001) 0.94
Linker for activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes: evaluation in normal and pathological conditions. Am J Pathol (1999) 0.93
Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. Br J Haematol (1990) 0.93
Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin Exp Immunol (1999) 0.92
A tetranucleotide repeat polymorphism in the cystic fibrosis gene. Hum Genet (1991) 0.92
Dipeptidyl(amino)peptidase IV (DAP-IV) histochemistry on normal and pathologic lymphoid tissues. Am J Clin Pathol (1982) 0.92
Alveolar macrophage-T cell interactions during Th1-type sarcoid inflammation. Microsc Res Tech (2001) 0.92
Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations. Mol Cell Probes (1992) 0.92
Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur Respir J (1997) 0.92
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol (1990) 0.91
Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J (1993) 0.91
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? Blood (1984) 0.91
Mechanism of interaction of the cyanine dye diS-C3-(5) with renal brush-border vesicles. J Membr Biol (1986) 0.90
Immunohistological analysis of Rosai-Dorfman histiocytosis. A disease of S-100 + CD1-histiocytes. Virchows Arch A Pathol Anat Histopathol (1987) 0.90
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. Gene Ther (1999) 0.90
Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector. Gene Ther (2001) 0.90
New clinical diagnostic procedures for cystic fibrosis in Europe. J Cyst Fibros (2011) 0.90
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol (2001) 0.90
Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood (1996) 0.90
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management. Pathologica (2013) 0.89
High serum level of soluble CD30 in acute primary HIV-1 infection. Clin Exp Immunol (1997) 0.89
Fluoride resistant alpha-naphthyl acetate esterase and combined enzyme histochemistry in the study of normal and pathologic lymphoid tissues. Basic Appl Histochem (1981) 0.89
Activation of mouse macrophages causes no change in expression and function of phorbol diesters' receptors, but is accompanied by alterations in the activity and kinetic parameters of NADPH oxidase. Immunology (1985) 0.89
Mediastinal large-cell lymphoma with sclerosis. Genotypic analysis establishes its B nature. Virchows Arch A Pathol Anat Histopathol (1987) 0.88
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology (1986) 0.88
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res (1984) 0.88
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia (2006) 0.88
The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.88